BIRMINGHAM, Ala. -- The Southeastern Conference in cooperation with its 14-member institutions announces the seventh annual "We Back Pat" Week, a week-long initiative focused on bringing awareness and recognition to the Pat Summitt Foundation, a fund of East Tennessee Foundation, and its fight against Alzheimer's disease.
SEC member institutions will support The Pat Summitt Foundation during their home basketball games, January 21-28. During the women's games slated for the week, various efforts will be made to increase awareness of The Pat Summitt Foundation.
The Pat Summitt Foundation Fund launched November 27, 2011 by Pat Summitt after her diagnosis of early onset dementia, Alzheimer's type at the age of 59. In a videotaped statement shown during the announcement of the Pat Summitt Foundation Fund, Pat Summitt said, "Tyler and I have decided to join this battle, not just for us, but also for the millions of families affected by this disease. I have always told our players, our greatest opportunities are disguised as our greatest obstacles. It is time to treat this obstacle as an opportunity and a stepping stone to a cure."
The Pat Summitt Foundation Fund will make grants to nonprofits which provide:
- Education and awareness of Alzheimer's, its onset and treatment
- Support services to patients, their families and caregivers
- Research to treat, prevent, cure, and ultimately eradicate this disease
About The Pat Summitt Foundation
The Pat Summitt Foundation, a fund of East Tennessee Foundation, was established by Pat Summitt in November 2011. Its mission is to award grants to non-profit organizations that advance research for treatment and a cure, provide support for patients and caregivers, and educate the public on Alzheimer's disease. In January 2015, The Pat Summitt Foundation formed a strategic partnership with The University of Tennessee Medical Center to create The Pat Summitt Clinic. The clinic, which opened in 2017, greatly improves access to healthcare services for families and patients facing Alzheimer's disease in a facility created to advance Alzheimer's research, detection, treatment, and family caregiver support.